Cell and Gene Commercialization

  1. The Hidden Risk In Cell & Gene Therapy Commercialization 6/5/2025

    Of the root causes of new product launch failure, insufficient relative advantage is by far the most important. Let's take a closer look at lessons we can learn from two key (approved) cell therapies.

  2. A Road Map For Transitioning From A Research-Focused To Commercialization Mindset 6/3/2025

    As the timeline for commercialization closes in, it’s necessary to best position the organization for a successful launch. Where to start?

  3. Accelerating Cell Therapy Development, Manufacturing Workflows 5/30/2025

    Realizing the full potential of modern cell therapies requires optimizing every stage of the process. Explore how advanced solutions can accelerate your development and manufacturing pipeline.

  4. How Combining Best-Of-Breed Technology And Services Can Ensure Commercial Success 5/29/2025

    Current "end-to-end" automation often forces sacrifices in cell therapy manufacturing. A strategy integrating specialized technologies for key bottlenecks like activation and expansion aims to improve efficiency.

  5. Navigating Regulatory Complexity In CGT Development, Commercialization 5/28/2025

    To successfully commercialize cell and gene therapies, understanding evolving US regulatory mandates is key. Consider these strategies to avoid delays and ensure compliance.

  6. Why Better Manufacturing Is the Key to Unlocking Cell Therapy's Full Potential 5/22/2025

    Emerging technologies are beginning to address the complex manufacturing challenges that have limited the scalability and accessibility of CAR-T and other cell therapies.

  7. 3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization 5/13/2025

    CTMC's Amy Hay provides 3 recommendations for teams developing cell and gene therapies, from clinical research through commercialization.

  8. Gene Therapy Solutions: From Discovery To Commercialization 5/7/2025

    Learn how advanced technologies and methodologies are driving progress in gene therapy, enabling safer and more effective treatments for rare and complex diseases.

  9. Implementing Complex Ordering Workflows Has Never Been Easier 5/6/2025

    Gain valuable program oversight with real-time monitoring and reporting. Stay informed and in control with comprehensive insights into your cell and gene therapy programs.

  10. Your Ally For Bringing CGTs From Discovery To Delivery 5/6/2025

    Bridging the divide between pioneering Cell and Gene Therapy and patient reality. Learn how focused strategies are empowering Biopharma to deliver life-altering treatments with greater speed and efficiency.